Featured Data Mosaic

Trending

Website

Regardless of Political Party, Americans Overwhelmingly Support Medicare Drug Price Negotiations

A new West Health-Gallup poll shows 83% of the U.S. population favors Medicare being allowed to negotiate with drug companies to lower prescription drug prices for its recipients.

February 26, 2025

9 Minute Read

As the pharmaceutical industry ramps up efforts to fight the U.S. government’s historic Medicare Drug Price Negotiation Program, a new West Health-Gallup public opinion survey shows overwhelming bipartisan support for the program, which is forecast to save $100 billion in its first decade.

Test test test

Image illustrating the topic of the article. Test test test

ACCORDION ACCESSIBILITY

BIG QUOTE ACCESSIBILITY

BIG QUOTE CONTENT.

Vlado Oravec,Quality Assurance Intern

Testing a list of items:

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris ullamcorper scelerisque dictum. Ut convallis viverra bibendum.
- Nunc non tristique neque. Donec convallis vitae enim eu efficitur. Donec sollicitudin, libero eget fringilla vulputate, magna diam viverra nunc, sed euismod risus dui at mi.
- Suspendisse potenti. Ut ante arcu, pulvinar in aliquam quis, accumsan vel nisi.
- Integer at tortor efficitur, accumsan sapien et, vehicula mauris.
Vestibulum ut semper orci, sed elementum ipsum. Nunc metus turpis, dignissim et fringilla sed, eleifend at massa.
Curabitur ullamcorper urna eu est aliquet, nec placerat quam commodo. Proin tincidunt orci quis justo consequat, non consequat justo elementum.
Suspendisse id posuere lacus, in elementum ante. Donec tempus dictum viverra.

“Across the board, community leaders, payers, government, and healthcare entities must jointly come together to provide evidence-based, scalable, equitable, and sustainable solutions.”

Maecenas scelerisque sem sed pretium vestibulum. Sed efficitur leo rhoncus nunc tristique, laoreet scelerisque nulla egestas. Integer faucibus ante et dictum tempor. Fusce ac lobortis orci. Cras non efficitur nulla.

Testing a list of items:

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris ullamcorper scelerisque dictum. Ut convallis viverra bibendum.
1. Nunc non tristique neque. Donec convallis vitae enim eu efficitur. Donec sollicitudin, libero eget fringilla vulputate, magna diam viverra nunc, sed euismod risus dui at mi.
2. Suspendisse potenti. Ut ante arcu, pulvinar in aliquam quis, accumsan vel nisi.
3. Integer at tortor efficitur, accumsan sapien et, vehicula mauris.
Vestibulum ut semper orci, sed elementum ipsum. Nunc metus turpis, dignissim et fringilla sed, eleifend at massa.
Curabitur ullamcorper urna eu est aliquet, nec placerat quam commodo. Proin tincidunt orci quis justo consequat, non consequat justo elementum.
Suspendisse id posuere lacus, in elementum ante. Donec tempus dictum viverra.

~~SMALL QUOTE ACCESSIBILITY~~

“SMALL QUOTE CONTENT”

Vlado Oravec,Quality Assurance Intern

“No matter who they vote for, Americans are suffering from the high costs of prescription drugs,” says Tim Lash, president of West Health, a family of nonprofit organizations focused on reducing healthcare costs and improving quality of

care. “The public’s

overwhelming support for this policy, even as we head into a presidential election, makes one thing exceedingly clear: people know unfair, anticompetitive behavior when they see it and they want it to stop.”

Heading H1

Heading H2

Heading H3

Heading H4

Heading H5

Heading H6

Table start

Tabel Header 1	Tabel Header 2	Tabel Header 3	Tabel Header 4	Tabel Header 5	Tabel Header 6
Table Row 1	Table Cell 1,2	Table Cell 1,3	Table Cell 1,4	Table Cell 1,5	Table Cell 1,6
Table Row 2	Table Cell 2,2	Table Cell 2,3	Table Cell 2,4	Table Cell 2,5	Table Cell 2,6
Table Row 3	Table Cell 3,2	Table Cell 3,3	Table Cell 3,4	Table Cell 3,5	Table Cell 3,6
Table Row 4	Table Cell 4,2	Table Cell 4,3	Table Cell 4,4	Table Cell 4,5	Table Cell 4,6

Table end

Large table

Table Header 1	Table Header 2	Table Header 3	Table Header 4	Table Header 5	Table Header 6	Table Header 7	Table Header 8	Table Header 9	Table Header 10	Table Header 11	Table Header 12	Table Header 13	Table Header 14
Table Row 1	Table Cell 1,2	Table Cell 1,3	Table Cell 1,4	Table Cell 1,5	Table Cell 1,6	Table Cell 1,2	Table Cell 1,3	Table Cell 1,4	Table Cell 1,5	Table Cell 1,6	Table Cell 1,2	Table Cell 1,3	Table Cell 1,4
Table Row 2	Table Cell 2,2	Table Cell 2,3	Table Cell 2,4	Table Cell 2,5	Table Cell 2,6	Table Cell 2,2	Table Cell 2,3	Table Cell 2,4	Table Cell 2,5	Table Cell 2,6	Table Cell 2,2	Table Cell 2,3	Table Cell 2,4
Table Row 3	Table Cell 3,2	Table Cell 3,3	Table Cell 3,4	Table Cell 3,5	Table Cell 3,6	Table Cell 3,2	Table Cell 3,3	Table Cell 3,4	Table Cell 3,5	Table Cell 3,6	Table Cell 3,2	Table Cell 3,3	Table Cell 3,4
Table Row 4	Table Cell 4,2	Table Cell 4,3	Table Cell 4,4	Table Cell 4,5	Table Cell 4,6	Table Cell 4,2	Table Cell 4,3	Table Cell 4,4	Table Cell 4,5	Table Cell 4,6	Table Cell 4,2	Table Cell 4,3	Table Cell 4,4

Large table end

^{TABLE ACCESSIBILITY}

HEADER1x1	HEADER1x2
BODY1x1	BODY2x2

This week, the Centers for Medicare & Medicaid Services (CMS) will publish the first 10 Medicare drugs selected for the Medicare Drug Price Negotiation Program, with revised prices taking effect January 2026. CMS will then select up to 15 more drugs for 2027, 15 more drugs for 2028, and 20 more drugs for each year after that, as outlined in the Inflation Reduction Act.
But pharmaceutical companies are seeking to block the program through lawsuits and other means, despite broad and enduring public support for Medicare’s ability to negotiate lower prices for the nation’s more-than 65 million Medicare enrollees.
The new West Health-Gallup survey shows 83% of Americans favor price negotiations between Medicare and pharmaceutical companies, including 95% of Democrats, 76% of Independents and 75% of Republicans. Similar levels of support were consistent across age, race, gender, income levels and education.
Dramatic savings are expected from the program. The Congressional Budget Office estimates negotiations directly between Medicare and drug makers could reduce spending by $3.7 billion in its first year and save more than $100 billion over the next decade. But even more importantly, it could save lives. According to a report prepared by the research arm of drug distributor AmerisourceBergen for West Health, 112,000 seniors could die prematurely each year because drug prices and associated costs are so high that they can’t afford their medication.
“Big Pharma’s high drug prices are killing us, fueling a public health and humanitarian crisis of its own,” Lash says. “Giving Medicare the power to negotiate is an important step, but we can’t lose sight of the fact that more reforms are needed. Anti-competitive behavior in healthcare is a burden for everyone, regardless of their politics.”

About the West Health-Gallup Survey

The new public opinion survey on Medicare drug price negotiations was carried out between May 30 and June 6 by Gallup in partnership with West Health. Gallup surveyed 2,145 adults living in all 50 U.S. states and the District of Columbia, All samples are weighted to correct for unequal selection probability and non-response. Post-stratification weighting takes into account gender, age, race, Hispanic ethnicity, education and region. Demographic weighting targets are based on the most recent Current Population Survey figures. The survey carries a margin of error at the 95% confidence level is +2.7 percentage points for response percentages around 50% and is +1.6 percentage points for response percentages around 10% or 90%, design effect included. For reported sub-groups, the margin of error will be larger, typically ranging from ±3.5 to ±6 percentage points.

Read Full Publication

Downloads

test

Download

About Article Source

test

Want to learn more?

You can learn more in the main deep dive article.

Dive Deeper

Regardless of Political Party, Americans Overwhelmingly Support Medicare Drug Price Negotiations

Related Articles You May Find Interesting

Heading H1